Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Is a | Disorder of hemostatic system | true | Inferred relationship | Some | ||
| Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Finding site | Entire hematological system (body structure) | false | Inferred relationship | Some | ||
| Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Finding site | Body system structure | false | Inferred relationship | Some | ||
| Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Has definitional manifestation | Hemostatic system finding | false | Inferred relationship | Some | ||
| Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Interprets | Haemostatic function | true | Inferred relationship | Some | 1 | |
| Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Has interpretation | Abnormal | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Deficiency of naturally occurring coagulation factor inhibitor | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Haemophilia carrier | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Factor VIII deficiency | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Contact factor deficiency (disorder) | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Prothrombin complex deficiency | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Fibrinogen abnormality | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Combined coagulation factor deficiency | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Fibrinolytic bleeding syndrome | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Acquired coagulation disorder | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Thrombophilia | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Acquired inhibitor of coagulation | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Blood coagulation disorder, categorized by value of screening test | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Includes true von Willebrand disease with mutation at the VWF locus, as well as mimicking disorders with other mutations (pseudo VWD) and acquired von Willebrand syndrome. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| A bleeding disorder with characteristics of mild to moderate mucocutaneous bleeding, which becomes more pronounced during pregnancy or following ingestion of drugs that have anti-platelet activity. This disease is due to hyperresponsive platelets, resulting in thrombocytopenia. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Lupus anticoagulant disorder | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Vascular hemostatic disease | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Platelet disorder (disorder) | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Anticoagulant overdosage | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Acquired coagulation factor inhibitor disorder | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Disseminated intravascular coagulation | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Familial hemorrhagic diathesis | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Blood coagulation disorder due to liver disease | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Hyperheparinemia | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Includes both quantitative and qualitative disorders of procoagulants | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Neonatal coagulation disorder | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Disorder involving the fibrinolytic system (disorder) | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Postpartum coagulation defects | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Other specified acquired coagulation factor deficiency | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Acquired coagulation factor deficiency NOS | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Purpura og andre hæmoragiske tilstande | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Clotting or bleeding disorder NOS | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| [X]Other specified coagulation defects | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| H/O: coagulation defect | Associated finding | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 1 |
| Thrombocytopenic disorder | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Kvalitativ trombocytforstyrrelse | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| ante partum-blødning med koagulationsdefekt, barn født | Associated with | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 1 |
| ante partum-blødning med koagulationsdefekt, barn ikke født | Associated with | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 1 |
| Intrapartum hemorrhage with coagulation defect | Associated with | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 2 |
| Antepartum hemorrhage with coagulation defect (disorder) | Associated with | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 2 |
| Ante partum-blødning med koagulationsdefekt, uspecificeret | Associated with | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Ante partum-blødning med koagulationsdefekt, ikke nærmere specificeret | Associated with | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| H/O: coagulation defect | Associated finding | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 1 |
| Clot retraction, screen | Has focus | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 2 |
| Blood coagulation disorder complicating childbirth | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Blood coagulation disorder complicating pregnancy (disorder) | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Family history of blood coagulation disorder | Associated finding | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 1 |
| Kasabach-Merritt syndrome | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Pancytopenia due to antineoplastic chemotherapy (disorder) | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Bleeding disorder due to CalDAG-GEFI deficiency is a rare hematologic disease due to defective platelet function and characterized by mucocutaneous bleeding starting in infancy (around 18 months of age), presenting with prolonged and severe epistaxis, hematomas and bleeding after tooth extraction. Massive menorrhagia and chronic anemia have also been reported. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| P2Y12 defect is a rare hemorrhagic disorder characterized by mild to moderate bleeding diathesis with easy bruising, mucosal bleeding, and excessive post-operative hemorrhage due to defect of the platelet P2Y12 receptor resulting in selective impairment of platelet responses to adenosine diphosphate. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Purpura of skin and/or skin-associated mucous membrane co-occurrent and due to coagulation disorder (disorder) | Due to | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 1 |
| Purpura of skin and/or skin-associated mucous membrane co-occurrent and due to coagulation disorder (disorder) | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Acquired thrombocytopenia | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Secondary thrombocytopenia | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Refractory thrombocytopenia (disorder) | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| A rare genetic coagulation disorder characterised by easy bruising (without haemarthrosis or spontaneous haematomas), epistaxis, menorrhagia, and excessive bleeding after minor trauma and surgical procedures. Patients present a prolonged prothrombin time and/or activated partial thromboplastin time, normal levels of all coagulation factors and normal protein C activity. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| A rare genetic constitutional coagulation factor defect disorder characterized by a bleeding tendency of variable severity due to methionine 358 to arginine replacement (Pittsburgh mutation) in the alpha-1-antitrypsin protein. Patients present with spontaneous hematomas, hematomas following minor trauma or surgery and in female patients ovarian hematomas after ovulation. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| A rare genetic coagulation disorder with characteristics of mild to moderate bleeding tendency due to impaired platelet activation and aggregation in response to collagen, or impaired platelet-vessel wall interaction, resulting from a collagen receptor defect. Patients manifest with ecchymoses, epistaxis, menorrhagia, and/or post-traumatic and post-surgery bleeding complications. Laboratory analysis reveals prolonged bleeding time and occasionally mild thrombocytopenia. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| A rare genetic isolated constitutional thrombocytopenia disease with characteristics of impaired platelet aggregation resulting from a defect in thromboxane synthesis or signaling, manifesting with mild to moderate mucocutaneous, gastrointestinal or surgical bleeding (for example easy bruising, prolonged epistaxis, excessive bleeding after a tooth extraction). Conferred by heterozygous mutation in the gene encoding the thromboxane A2 receptor (TBXA2R) on chromosome 19p13. | Is a | False | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| A rare life-threatening genetic coagulation disorder with characteristics of an increased risk of blood clot formation in several members of a family due to a thrombomodulin gene mutation. Patients may manifest with venous thromboembolic disease, premature myocardial infarction and/or arterial thrombosis. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Consumption coagulopathy caused by snake venom | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Abnormal uterine bleeding due to coagulopathy (disorder) | Due to | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 2 |
| Menorrhagia due to bleeding disorder | Due to | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 1 |
| Glomerular disease due to coagulation disorder | Due to | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 2 |
| Antepartum hemorrhage with coagulation defect (disorder) | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| A rare genetic coagulation disorder characterized by marked bleeding tendency and posttraumatic bleeding with easy bruising, soft tissue and muscle bleeding, hemarthroses, and menorrhagia due to an increase of soluble thrombomodulin in plasma with subsequent protein C activation and reduction of thrombin generation within a potential thrombus. Abnormal laboratory findings include markedly elevated plasma thrombomodulin, reduced prothrombin consumption, and decreased thrombin generation. | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Intrapartum hemorrhage with coagulation defect | Is a | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | |
| Occlusion of microvasculature of skin due to coagulopathy | Due to | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 2 |
| Excessive bleeding due to blood coagulation disorder | Due to | True | Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. | Inferred relationship | Some | 2 |
This concept is not in any reference sets
FHIR